Abstract
Aim
There are scanty data on the rate of abnormal Tc-99 m dimercaptosuccinic acid (DMSA) renal scintigraphy and associated factors in children older than 5 years with diagnosis of VUR. We do not have knowledge about which older children should undergo DMSA after VUR diagnosis. This study aims to assess the rate of abnormal DMSA findings and associated factors in children older than 5 years of age diagnosed with VUR.
Materials and methods
We retrospectively reviewed the medical records of 258 children with VUR diagnosed at or older than 5 year age. 179 children [42 (23.5%) males and 137 (76.5%) females] with complete data were included. 268 reflux units were compared according to gender, bilaterality, grade, reflux phase at voiding cystourethrography, febrile urinary tract infection (fUTI), lower urinary tract dysfunction (LUTD), and DMSA findings with uni- and multivariate analysis.
Results
The median age was 110 (60–216) months. VUR grades were I, II, and III in 197 (73.6%) units and IV–V in 71 (26.4%). 138 (51.5%) renal units had abnormal DMSA. VUR grade (p < 0.01), unilaterality (p = 0.048), and fUTI (p = 0.031) in univariate but only grade and unilaterality in multivariate analysis are significantly associated with abnormal DMSA. Although reflux at filling phase was predominant in high-grade VUR group, reflux at voiding phase (p = 0.006) in low–medium-grade (1–3) VUR was associated with abnormal DMSA.
Conclusion
Children older than 5 years of age diagnosed with VUR should be regarded as a high-risk group for abnormal DMSA regardless of gender, unilaterality, grade, reflux phase, fUTI, and LUTD.
Similar content being viewed by others
References
Skoog SJ, Peters CA, Arant BS, Copp HL, Elder JS, Hudson RG et al (2010) Pediatric vesicoureteral reflux guidelines panel summary report: clinical practice guidelines for screening siblings of children with vesicoureteral reflux and neonates/infants with prenatal hydronephrosis. J Urol 184(3):1145–1151
Hajiyev P, Burgu B (2017) Contemporary management of vesicoureteral reflux. Eur Urol Focus 3(2–3):181–188
Radmayr C, Bogaert G, Dogan H, Kočvara R, Nijman J, Stein R (2019) EAU guidelines on paediatric urology. In: Radmayr C, Bogaert G, Dogan H, Kočvara R, Nijman J, Stein R (eds) EAU Guidelines, edition presented at the annual EAU Congress Barcelona. EAU
Peters CA, Skoog SJ, Arant BS, Copp HL, Elder JS, Hudson RG et al (2010) Summary of the AUA guideline on management of primary vesicoureteral reflux in children. J Urol 184(3):1134–1144
Arsanjani A, Alagiri M (2007) Identification of filling versus voiding reflux as predictor of clinical outcome. Urology 70(2):351–354
Lee JN, Lee SM, Ha Y-S, Kim BS, Kim HT, Kim T-H et al (2016) VUR timing on VCUG as a predictive factor of VUR resolution after endoscopic therapy. J Pediatr Urol 12(4):255 e1–e6
McMillan ZM, Austin JC, Knudson MJ, Hawtrey CE, Cooper CS (2006) Bladder volume at onset of reflux on initial cystogram predicts spontaneous resolution. J Urol 176(4S):1838–1841
Garcia-Roig M, Ridley DE, McCracken C, Arlen AM, Cooper CS, Kirsch AJ (2017) Vesicoureteral reflux index: predicting primary vesicoureteral reflux resolution in children diagnosed after age 24 months. J Urol 197(4):1150–1157
Scherz HC, Downs TM, Caesar R (1994) The selective use of dimercaptosuccinic acid renal scans in children with vesicoureteral reflux. J Urol 152(2 Pt 2):628–631
Garin EH, Olavarria F, Nieto VG, Valenciano B, Campos A, Young L (2006) Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics 117(3):626–632
Mattoo TK, Chesney RW, Greenfield SP, Hoberman A, Keren R, Mathews R et al (2016) Renal scarring in the randomized intervention for children with vesicoureteral reflux (RIVUR) trial. Clin J Am Soc Nephrol 11(1):54–61
Pennesi M, Travan L, Peratoner L, Bordugo A, Cattaneo A, Ronfani L et al (2008) Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics 121(6):e1489–e1494
Montini G, Rigon L, Zucchetta P, Fregonese F, Toffolo A, Gobber D et al (2008) Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics 122(5):1064–1071
Craig JC, Simpson JM, Williams GJ, Lowe A, Reynolds GJ, McTaggart SJ et al (2009) Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med 361(18):1748–1759
Brandström P, Nevéus T, Sixt R, Stokland E, Jodal U, Hansson S (2010) The Swedish reflux trial in children: IV renal damage. J Urol 184(1):292–297
Lebowitz R, Olbing H, Parkkulainen K, Smellie J, Tamminen-Möbius T (1985) International system of radiographic grading of vesicoureteric reflux. Pediatr Radiol 15(2):105–109
Nakamura M, Moriya K, Mitsui T, Tanaka H, Nonomura K (2009) Abnormal dimercapto-succinic acid scan is a predictive factor of breakthrough urinary tract infection in children with primary vesicoureteral reflux. J Urol 182(4 Suppl):1694–1697
Frimberger D, Mercado-Deane MG (2016) Establishing a standard protocol for the voiding cystourethrography. Pediatrics. https://doi.org/10.1542/peds.2016-2590
Akbal C, Genc Y, Burgu B, Ozden E, Tekgul S (2005) Dysfunctional voiding and incontinence scoring system: quantitative evaluation of incontinence symptoms in pediatric population. J Urol 173(3):969–973
Austin PF, Bauer SB, Bower W, Chase J, Franco I, Hoebeke P et al (2016) The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the International Children’s Continence Society. Neurourol Urodyn 35(4):471–481
Koff SA (1983) Estimating bladder capacity in children. Urology 21(3):248
Doğan ÇS, Koyun NS, Aksoy GK, Çekiç B, Savaş M, Çomak E (2018) Delayed diagnosis of primary vesicoureteral reflux in children with recurrent urinary tract infections: diagnostic approach and renal outcomes. Turk J Urol 44(6):498
Han DS, Cambareri G, Alagiri M, Chiang G (2019) Reflux timing is a predictor of successful endoscopic treatment of vesicoureteral reflux. Urology 124:237–240
Alexander SE, Arlen AM, Storm DW, Kieran K, Cooper CS (2015) Bladder volume at onset of vesicoureteral reflux is an independent risk factor for breakthrough febrile urinary tract infection. J Urol 193(4):1342–1346
Sillé U, Bachelard M, Hansson S, Stokland E (2004) Spontaneous resolution of high grade infantile vesicoureteral reflux. J Urol 172(2):694–699
Arlen AM, Alexander SE, Wald M, Cooper CS (2016) Computer model predicting breakthrough febrile urinary tract infection in children with primary vesicoureteral reflux. J Pediatr Urol 12(5):288 e1–e5
Hidas G, Billimek J, Nam A, Soltani T, Kelly MS, Selby B et al (2015) Predicting the risk of breakthrough urinary tract infections: primary vesicoureteral reflux. J Urol 194(5):1396–1401
Funding
The authors declared that this study received no financial support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No conflict of interest was declared by the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ergun, R., Sekerci, C.A., Tanidir, Y. et al. Abnormal DMSA renal scan findings and associated factors in older children with vesicoureteral reflux. Int Urol Nephrol 53, 1963–1968 (2021). https://doi.org/10.1007/s11255-021-02934-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-021-02934-3